Litcius/Paper detail

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma

Shuo Liu, Zhen Qin, Yaqing Mao, Wenbo Zhang, Yujia Wang, Lingfei Jia, Xin Peng

2022OncoImmunology56 citationsDOIOpen Access PDF

Abstract

T cell in HNSCC correlated with poor prognosis. These results suggested the potential of small-molecule MYC inhibitors as anti-cancer therapeutic agents in HNSCC.

Topics & Concepts

Cancer researchHead and neck squamous-cell carcinomaCD8CarcinogenesisCellImmunotherapyMedicineHead and neck cancerCell growthCell cultureT cellCancerImmune systemBiologyImmunologyInternal medicineGeneticsinterferon and immune responsesUbiquitin and proteasome pathwaysProtein Degradation and Inhibitors
Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma | Litcius